Forster C, Armstrong P W
Division of Cardiology, St. Michael's Hospital, University of Toronto, Ontario, Canada.
J Cardiovasc Pharmacol. 1990 Nov;16(5):708-18. doi: 10.1097/00005344-199011000-00004.
Postjunctional alpha-adrenoceptor characteristics were evaluated in canine dorsal pedal arterial and saphenous vein rings studied before and after development of severe pacing-induced heart failure (CHF). Before CHF, all agonists produced concentration-dependent increases in tension of both blood vessels. After development of CHF, the responsiveness and sensitivity of the vessels to the alpha 1-agonists and the mixed agonists were significantly increased as compared with control. The maximum responses to BHT 920 and BHT 933 remained unaltered after CHF, but both vessels showed decreased sensitivity to BHT 920. Before CHF, the rank order of potency with respect to norepinephrine (NE) for the dorsal pedal artery was as follows: NE greater than epinephrine greater than methoxamine greater than BHT 933 greater than BHT 920, and for the saphenous vein was epinephrine greater than NE greater than BHT 933 greater than methoxamine greater than BHT 920. At peak CHF, the rank order of potency for the artery was epinephrine greater than NE greater than methoxamine greater than BHT 933 greater than BHT 920, whereas in the vein BHT 920 was approximately 80 times less potent than NE (as compared with being only five times less potent before CHF). Prazosin was a potent, competitive antagonist (pA2 values of 9.2 and 9.0 for the artery and the vein) of methoxamine-induced contractions before development of CHF. Prazosin had a 10-fold lower potency against epinephrine-induced contractions in the dorsal pedal artery, whereas it was not competitive against epinephrine in the saphenous vein. Against the selective alpha 2-agonists, prazosin either showed no antagonism or was not competitive. After CHF, prazosin was non competitive against all agonists tested. Yohimbine was a potent, competitive antagonist against BHT 920 both before and at CHF. Yohimbine had intermediate antagonism against epinephrine and produced no antagonism of methoxamine-induced contractions. We conclude that increased reactivity and sensitivity of the peripheral vasculature to alpha 1-agonists occurs at CHF.
在严重起搏诱导的心力衰竭(CHF)发生前后,对犬背侧足背动脉和隐静脉环的节后α-肾上腺素能受体特性进行了评估。在CHF发生前,所有激动剂均使两种血管的张力呈浓度依赖性增加。CHF发生后,与对照组相比,血管对α1-激动剂和混合激动剂的反应性和敏感性显著增加。CHF发生后,对BHT 920和BHT 933的最大反应保持不变,但两种血管对BHT 920的敏感性均降低。在CHF发生前,背侧足背动脉对去甲肾上腺素(NE)的效价顺序如下:NE>肾上腺素>甲氧明>BHT 933>BHT 920,隐静脉的顺序为:肾上腺素>NE>BHT 933>甲氧明>BHT 920。在CHF高峰期,动脉的效价顺序为:肾上腺素>NE>甲氧明>BHT 933>BHT 920,而在静脉中,BHT 920的效价比NE低约80倍(CHF发生前仅低5倍)。在CHF发生前,哌唑嗪是甲氧明诱导收缩的强效竞争性拮抗剂(动脉和静脉的pA2值分别为9.2和9.0)。哌唑嗪对背侧足背动脉中肾上腺素诱导的收缩的效价低10倍,而在隐静脉中对肾上腺素无竞争性。对于选择性α2-激动剂,哌唑嗪要么无拮抗作用,要么无竞争性。CHF发生后,哌唑嗪对所有测试的激动剂均无竞争性。育亨宾在CHF发生前和发生时都是BHT 920的强效竞争性拮抗剂。育亨宾对肾上腺素具有中度拮抗作用,对甲氧明诱导的收缩无拮抗作用。我们得出结论,在CHF时外周血管对α1-激动剂的反应性和敏感性增加。